List of Drug Master Files (KDMF) of Active Pharmaceutical Ingredients (APIs) submitted by Pfizer Inc to the Review Authority in Korea.

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across...
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative bioph

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
235 East 42nd Street New York, NY 10017
Telephone
Telephone
+1 212-733-2323

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

CPhI Worldwide, Milan

CPhI Worldwide, Milan

Not Confirmed

envelop Contact Supplier

CPhI Worldwide, Milan

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
“We’re unlocking life-changing potential in complex molecules, without sacrificing time to market”
This week, SpeakPharma interviews Mike Riley, CEO of Veranova, a leading contract development and manufacturing organization (CDMO) confidently mastering complex APIs as it marks its second year as an independent company. Riley discusses Veranova’s key achievements, including a US$ 30 million investment in their Devens, Massachusetts (US) site to expand capabilities in antibody-drug conjugates (ADCs) and highly potent APIs (HPAPIs), and how it is navigating the increasing complexity of molecules. 🔑 HIGHLIGHTS// Veranova’s key achievements / navigating the increasing complexity of molecules Veranova is celebrating its second year as a stand-alone company. Can you share Veranova’s key milestones and achievements in its first two years? We have achieved incredible milestones over the last two years, thanks to the dedication and hard work of our team. Our first 12 months focused on establishing ourselves as an independent CDMO by building on the 50 years of expertise that we brought with us. In addition, we expanded our capabilities and applied a more agile approach available to us as a company singularly focused on life sciences. This has allowed us to move into our second year with clear and strategic goals for generating growth in our sites, people, capabilities, and offerings. Since being appointed as CEO in May 2023, I’ve had the pleasure of witnessing some exciting growth milestones of my own. Most recently, we announced an estimated US$ 30 million investment in our Devens, Massachusetts, site. This expansion will allow us to build upon existing development and manufacturing capabilities in ADCs and HPAPIs that will address the growing demand for strong US-based capacity in these key drug modalities. We also appointed our Advisory Board, thereby bolstering Veranova’s in-house expertise. Made up of four distinguished leaders in pharma and biopharma – including Dr. Carolyn Bertozzi, the 2022 Nobel Laureate in Chemistry – the Board has provided thought-leadership, guidance and expertise as we develop and execute our strategic growth and ideas. We were also proud to be recognized as one of the Society of Chemical Manufacturers and Affiliates’ 12 companies for industry-leading safety programs in 2023 and as a part of the Medicine Maker’s Power List in 2024. 🔑 HIGHLIGHTS// US$ 30 million investment in our Devens, Massachusetts, site / appointed our Advisory Board Molecules are becoming increasingly complex. Can you elaborate on how Veranova’s current capabilities are strategically designed to address this trend in the coming years? The pharmaceutical pipeline is witnessing an increasing number of complex and highly potent molecules. This trend is driven by the demand for more targeted, patient-centric therapeutics and the focus on innovative modalities such as ADCs and other bioconjugates. At Veranova, our expertise, world-class facilities, and scientific excellence enable us to provide our customers with the clarity and solutions needed to manage this development and manufacturing complexity and ultimately deliver the required treatments to customers and patients. Our people are key to this approach. We have an expert team ready to collaborate with customers at any point, from early development through large-scale commercial production. Our services include world-leading crystallization development, process development, and specialized manufacturing expertise for complex synthetic molecules, including those requiring chromatography capabilities. In many cases, we can provide all these under one roof. Our service offering to our customers is also based on the foundational element of strong quality and compliance systems. We operate multiple facilities approved by the US FDA, UK’s MHRA and other regulatory authorities and are continually focused on ways to strengthen our global quality management system. Looking ahead, we are focused on continually investing in our facilities and team to meet growing complexity, as evidenced by our recent announcement of new investment in our Devens site. This investment signals our commitment to providing state-of-the-art capacity and capabilities to enable these next-generation therapies to reach patients. It is a key milestone as we advance Veranova’s broader growth strategy. 🔑 HIGHLIGHTS// provide our customers with clarity and solutions / world-leading crystallization development / expertise for complex synthetic molecules / strong quality and compliance systems How is Veranova approaching the challenge of designing and manufacturing effective linker molecules for ADCs? As a leader in complex linker-payload synthesis, Veranova is committed to unlocking the life-changing potential of ADCs without letting their complexities slow down the development of much-needed cancer therapies. ADCs are intricate, multi-component molecules that require extensive expertise and agile collaboration to overcome unique development challenges. With over a decade of experience in ADC linker-payload systems, we have developed the ability to anticipate challenges and avoid common pitfalls. The ADC linker-payload components are complex structures that are difficult to crystallize and require specialized high-potent handling. Veranova’s differentiated combination of world-leading crystallization development capabilities, complex synthesis experience, chromatography expertise and high-potent-handling experience put us in a unique position to solve these challenges for customers and speed their products to the clinic. We prioritize getting it right the first time, minimizing change orders and ensuring high-quality results. We have developed a robust phase-appropriate strategy that is backed by state-of-the-art analytical equipment and regulatory procedures to ensure our partners can rapidly progress their ADC projects from pre-clinical to commercialization. 🔑 HIGHLIGHTS// unlocking the life-changing potential of ADCs / ensuring our partners can rapidly progress their ADC projects Can you specify how Veranova is using artificial intelligence (AI) to optimize manufacturing processes that can reduce costs and environmental footprint as well as speed up development? In May 2024, Veranova announced a partnership with Phorum.AI to leverage AI to optimize pharmaceutical manufacturing processes. This collaboration aims to enable the rapid development of processes that can drive efficiency and reduce costs while maximizing environmental sustainability. Our goal is to combine Veranova’s extensive empirical manufacturing dataset of owned APIs and drug master files with Phorum.AI’s computational chemistry engine in order to create a more powerful process-development tool for the benefit of Veranova’s and Phorum’s customers. At Veranova, we are constantly looking to employ innovative technologies and approaches to improve efficiency, accelerate time to market and reduce environmental footprint. We have the means to work with a variety of partners who have unique project requirements, without sacrificing time to market.  🔑 HIGHLIGHTS// partnership with Phorum.AI / create a more powerful process-development tool / improve efficiency, accelerate time to market and reduce environmental footprint

Impressions: 1659

https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market

#SpeakPharma With Veranova
10 Sep 2024

VLOG #PharmaReel

[Sponsored by another company]

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
Excipient Market Overview: Roquette, Seqens, Evonik make strategic moves; new guidelines deal with contamination
The pharmaceutical industry has long recognized the critical role excipients or inactive ingredients play in drug formulation and delivery. Excipients can comprise up to 90 percent of a medicine's total ingredients and serve crucial functions as binders, disintegrants, coatings, preservatives, colors, and flavorings. According to recent market research, the pharmaceutical excipients market was valued at US$ 9.27 billion in 2023. It is growing at a compound annual growth rate (CAGR) of 7.03 percent and is projected to reach US$ 18.48 billion by 2032. The main factors driving market growth is an increased demand for multifunctional excipients, coupled with the expanding use of generic medications. The development in the biologics sector and advancements in nanotechnology are also contributing significantly to market growth. Major excipient providers include BASF, Evonik, Merck KGaA owned MilliporeSigma, Gangwal Healthcare, Roquette Frères, DuPont, Croda International, Seqens, Boai NKY Pharmaceuticals, PMC Isochem, Minakem, Kewpie Corporation, Ashland Global, SPI Pharma, Pfanstiehl, Nanjing Well Pharmaceutical, ICE Pharma, Anhui Ribobay Pharmaceutical and Nippon Fine Chemical.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available) WHO, India’s CDSCO tighten regulations; new GMP guidelines implemented to curb contamination Last year, the World Health Organization (WHO) issued a health alert linking at least 300 child deaths in the Gambia, Uzbekistan, and Indonesia to the ingestion of contaminated cough syrups containing unacceptable levels of diethylene glycol (DEG) and ethylene glycol (EG). In response to the tragic events, the WHO released two draft appendices to its guideline on good manufacturing practices (GMPs) for excipients this year. Manufacturers are now required to use suitable risk assessment tools to identify and mitigate potential hazards.  Since India-made cough syrups had been linked to the deaths, India’s drug regulator — Central Drugs Standard Control Organization (CDSCO) — took steps to prevent contamination, and advised drugmakers to only use pharmaceutical-grade excipients from approved sources. Furthermore, the Indian Health Ministry proposed amendments to the Drugs and Cosmetics Rules, 1945 to include details of excipients on drug labels. While listing all excipients on every strip of medicine may be challenging, the ministry suggested mentioning those causing hypersensitivity on the label. Applicants now mandatorily need to submit evidence of stability and safety of excipients. These regulatory developments have significant implications for excipient manufacturers and pharmaceutical companies worldwide. Leading pharmaceutical excipient firms like Gangwal Healthcare, Sigachi Industries, and Nitika Pharmaceuticals are well-positioned to meet these heightened quality and safety standards, given their long-standing commitment to producing high-quality, compliant excipients.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Roquette buys IFF’s pharma unit for US$ 2.85 bn; Evonik opens new spray-drying facility in Darmstadt In a significant industry move, France-based Roquette entered into an agreement to acquire IFF's pharma solutions business in a deal valued at US$ 2.85 billion. This acquisition is set to rebalance family-owned Roquette’s portfolio around health and nutrition. The deal is expected to accelerate Roquette’s growth and significantly strengthen its presence in the excipients market. Evonik has opened a new facility for drying aqueous dispersions of its Eudragit polymers at its site in Darmstadt, Germany. The facility will help Evonik meet increasing demand from drugmakers for its oral drug delivery solutions. The plant uses green energy solutions. The company has also partnered University of Mainz to commercialize a new class of polyethylene glycols (PEG) lipids for nucleic acid delivery. Evonik’s Health Care business has been growing its nucleic acid drug and vaccine delivery portfolio.  Germany’s Johannes Gutenberg University of Mainz was the first to develop randomized polyethylene glycols (rPEGs). This collaboration aims to expand Evonik’s toolbox of technologies for nucleic acid-based medicines, offering an improved immunogenicity profile for lipid nanoparticle carriers used in mRNA vaccines and therapeutics. Asahi Kasei made significant strides in addressing a pressing industry concern that emerged in 2018 when potentially carcinogenic nitrosamine impurities were detected in several pharmaceuticals. Guided by regional authorities, such as the European Medicines Agency and the US Food and Drug Administration, the pharmaceutical industry has been carrying out extensive assessments and research to identify the cause of these impurities. In response to this challenge, Asahi Kasei developed its Ceolus microcrystalline cellulose with extremely low nitrite levels. The Japanese company achieved nitrite concentrations of 0.1 micrograms per gram or less, which is equivalent to 0.1 parts per million (ppm). The company also started full commercial operation of its second manufacturing facility for Ceolus in Japan, enhancing supply capacity and stability. JRS Pharma and Gujarat Microwax opened a state-of-the-art cotton-based croscarmellose sodium plant in Mehsana, Gujarat (India). This facility aims to produce high-quality excipients that meet global standards, potentially reducing India's dependency on imports and boosting its presence in the global excipient market. The Indian excipient industry accounts for less than 1 percent of the global market share.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Seqens to advance innovative polymer; biologics, personalized medicine create demand for specialized excipients Recent industry collaborations highlight the ongoing innovation in novel excipients. France’s Seqens, with over 20 years of polymer development experience, was chosen by Pleryon Therapeutics to advance its leading osteoarthritis candidate – an innovative GMP polymer. This collaboration leverages Seqens’ newly expanded and modernized cGMP plant in Aramon, France, demonstrating the industry’s commitment to investing in advanced manufacturing capabilities for novel excipients.  The rise of biologics and personalized medicine has created a demand for specialized excipients capable of stabilizing complex molecules and enabling targeted drug delivery. Roquette’s launch of Lycagel Flex, a hydroxypropyl pemix for nutraceutical and pharmaceutical softgel capsules, exemplifies this trend. Built on Roquette’s market-first Lycagel pea starch technology, this plant-based alternative to gelatin offers manufacturers the flexibility to customize formulations for a range of production and end-user needs. The innovative pea starch foundation also underscores the industry’s move towards sustainable bio-based excipients. The trend towards patient-centric drug development has also influenced excipient innovation. Excipients that can improve palatability, ease of swallowing, or enable novel dosage forms (such as orally disintegrating tablets) are in high demand. For example, IFF brought a super disintegrant Ac-Di-Sol, that supports faster disintegration and drug dissolution in oral disintegrating tablets, improving patient experience.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Our view The heightened regulatory scrutiny on excipients due to product contamination incidents has created a high risk perception and uncertainty around the regulatory acceptance of novel excipients. That said, novel excipients are central to the development of new drug modalities and therapies. Going forward, sustainability will also become an increasingly important factor in excipient selection and development. As the industry innovates towards biologics, personalized therapies, and patient-centric formulations, the role of high-quality, multifunctional excipients will only grow more vital in ensuring drug stability, bioavailability, and patient compliance. Companies that can navigate the complex regulatory landscape, invest in R&D, and offer high-quality, multifunctional excipients will be well-positioned to succeed in this evolving market.   

Impressions: 727

https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination

#PharmaFlow by PHARMACOMPASS
12 Sep 2024

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20240917734330/en

BUSINESSWIRE
17 Sep 2024

https://pharmaphorum.com/news/esmo-pfizer-drug-helps-cancer-patients-gain-weight

#N/A
17 Sep 2024

https://www.businesswire.com/news/home/20240913347614/en

BUSINESSWIRE
16 Sep 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-pushing-braf-lung-cancer-mutation-testing-grow-market-braftovi-2024-09-14/

Michael Erman REUTERS
14 Sep 2024

https://www.businesswire.com/news/home/20240913128678/en

BUSINESSWIRE
14 Sep 2024

https://www.businesswire.com/news/home/20240910073933/en

BUSINESSWIRE
11 Sep 2024

Excipients

Click here to find the perfect excipient manufacturers by their capabilities

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Pfizer Inc and get a quotation

Pfizer Inc is a supplier offers 213 products (APIs, Excipients or Intermediates).

Find a price of Betamethyl Epoxide bulk with DMF, JDMF offered by Pfizer Inc

Find a price of Epoprostenol Sodium bulk with DMF, JDMF offered by Pfizer Inc

Find a price of Methylprednisolone bulk with DMF, CEP offered by Pfizer Inc

Find a price of Prednisolone bulk with JDMF offered by Pfizer Inc

Find a price of Atorvastatin bulk with JDMF offered by Pfizer Inc

Find a price of Dexamethasone bulk with JDMF offered by Pfizer Inc

Find a price of Estradiol Cypionate bulk with DMF offered by Pfizer Inc

Find a price of Estramustine Phosphate Sodium bulk with DMF offered by Pfizer Inc

Find a price of Methylprednisolone Acetate bulk with DMF offered by Pfizer Inc

Find a price of Alprazolam bulk with CEP offered by Pfizer Inc

Find a price of Betamethasone bulk offered by Pfizer Inc

Find a price of Betamethasone Valerate bulk offered by Pfizer Inc

Find a price of Cabergoline bulk offered by Pfizer Inc

Find a price of Calicheamicin bulk with DMF offered by Pfizer Inc

Find a price of CAS 50-28-2 bulk offered by Pfizer Inc

Find a price of Celecoxib bulk with JDMF offered by Pfizer Inc

Find a price of Chlormadinone Acetate bulk with JDMF offered by Pfizer Inc

Find a price of Clindamycin Palmitate bulk with DMF offered by Pfizer Inc

Find a price of Clindamycin Phosphate bulk with DMF offered by Pfizer Inc

Find a price of Cortisone bulk offered by Pfizer Inc

Find a price of Diflorasone bulk offered by Pfizer Inc

Find a price of Dinoprostone bulk with DMF offered by Pfizer Inc

Find a price of Doxorubicin Hydrochloride bulk with DMF offered by Pfizer Inc

Find a price of Flumethasone bulk offered by Pfizer Inc

Find a price of Fluoxymesterone bulk offered by Pfizer Inc

Find a price of Glipizide bulk with DMF offered by Pfizer Inc

Find a price of Hydrocortisone Sodium Succinate bulk with CEP offered by Pfizer Inc

Find a price of Lincomycin Hydrochloride bulk with DMF offered by Pfizer Inc

Find a price of Megestrol Acetate bulk with DMF offered by Pfizer Inc

Find a price of Methylprednisolone bulk offered by Pfizer Inc

Find a price of Methylprednisolone Hemisuccinate bulk with CEP offered by Pfizer Inc

Find a price of Piperacillin Sodium bulk offered by Pfizer Inc

Find a price of Piroxicam bulk with CEP offered by Pfizer Inc

Find a price of Prednisolone Acetate bulk offered by Pfizer Inc

Find a price of Progesterone bulk with JDMF offered by Pfizer Inc

Find a price of Triamcinolone bulk offered by Pfizer Inc

Find a price of Triamcinolone Acetonide bulk offered by Pfizer Inc

Find a price of Triamcinolone Diacetate bulk offered by Pfizer Inc

Find a price of 9-Aminocamptothecin bulk offered by Pfizer Inc

Find a price of Acecainide bulk offered by Pfizer Inc

Find a price of Acivicin bulk offered by Pfizer Inc

Find a price of Amphotericin B bulk offered by Pfizer Inc

Find a price of Ampicillin Sodium bulk offered by Pfizer Inc

Find a price of Ampicillin Trihydrate bulk offered by Pfizer Inc

Find a price of Arginine Vasopressin bulk offered by Pfizer Inc

Find a price of Arlitene bulk offered by Pfizer Inc

Find a price of Aspirin bulk offered by Pfizer Inc

Find a price of Bacampicillin bulk offered by Pfizer Inc

Find a price of Bacitracin Zinc bulk offered by Pfizer Inc

Find a price of Benzylpenicillin Sodium bulk offered by Pfizer Inc

Find a price of Betamethasone Benzoate bulk offered by Pfizer Inc

Find a price of Betamethasone Dipropionate bulk offered by Pfizer Inc

Find a price of Carbenicillin Indanyl bulk offered by Pfizer Inc

Find a price of Carboxylic Acid bulk offered by Pfizer Inc

Find a price of CAS 71-58-9 bulk offered by Pfizer Inc

Find a price of Cefixime bulk offered by Pfizer Inc

Find a price of Cefoperazone Sodium bulk offered by Pfizer Inc

Find a price of Chloramphenicol Palmitate bulk offered by Pfizer Inc

Find a price of Chloramphenicol Succinate Acid bulk offered by Pfizer Inc

Find a price of Chlorhexidine Gluconate bulk offered by Pfizer Inc

Find a price of Chlorpropamide bulk offered by Pfizer Inc

Find a price of Chlortetracycline Hydrochloride bulk offered by Pfizer Inc

Find a price of Chondroitin Sulfate Sodium bulk offered by Pfizer Inc

Find a price of Clindamycin Hydrochloride bulk offered by Pfizer Inc

Find a price of Clindamycin Phosphate bulk offered by Pfizer Inc

Find a price of Cycloheximide bulk offered by Pfizer Inc

Find a price of Cytarabine bulk offered by Pfizer Inc

Find a price of Dacarbazine bulk offered by Pfizer Inc

Find a price of Deferoxamine Mesylate bulk offered by Pfizer Inc

Find a price of Demeclocycline Hydrochloride bulk offered by Pfizer Inc

Find a price of Diphenhydramine bulk offered by Pfizer Inc

Find a price of Doxorubicin Hydrochloride bulk offered by Pfizer Inc

Find a price of Doxycycline Hyclate bulk offered by Pfizer Inc

Find a price of Edoxudin bulk offered by Pfizer Inc

Find a price of Erythromycin bulk offered by Pfizer Inc

Find a price of Erythromycin Stearate bulk offered by Pfizer Inc

Find a price of Estradiol bulk offered by Pfizer Inc

Find a price of Estramustine bulk offered by Pfizer Inc

Find a price of Ethinyl Estradiol bulk offered by Pfizer Inc

Find a price of Etodolac bulk offered by Pfizer Inc

Find a price of Exemestane bulk offered by Pfizer Inc

Find a price of Fedotozine Tartrate bulk offered by Pfizer Inc

Find a price of Fludrocortisone Acetate bulk offered by Pfizer Inc

Find a price of Fluocinolone Acetonide bulk offered by Pfizer Inc

Find a price of Fluorometholone bulk offered by Pfizer Inc

Find a price of Hydrocortisone bulk offered by Pfizer Inc

Find a price of Hydrocortisone Sodium Succinate bulk offered by Pfizer Inc

Find a price of Hydrogen Peroxide bulk offered by Pfizer Inc

Find a price of Hydroxyprogesterone Caproate bulk offered by Pfizer Inc

Find a price of Ibuprofen bulk offered by Pfizer Inc

Find a price of Idarubicin Hydrochloride bulk offered by Pfizer Inc

Find a price of Lysergic Acid bulk offered by Pfizer Inc

Find a price of Lysine Hydrochloride bulk offered by Pfizer Inc

Find a price of Meclofenamic Acid bulk offered by Pfizer Inc

Find a price of Medroxyprogesterone Acetate bulk offered by Pfizer Inc

Find a price of Medrysone bulk offered by Pfizer Inc

Find a price of Menogarol bulk offered by Pfizer Inc

Find a price of Metergoline bulk offered by Pfizer Inc

Find a price of Methacycline Hydrochloride bulk offered by Pfizer Inc

Find a price of Methaqualone bulk offered by Pfizer Inc

Find a price of Methotrexate bulk offered by Pfizer Inc

Find a price of Methyl Testosterone bulk offered by Pfizer Inc

Find a price of Methylprednisolone Hemisuccinate bulk offered by Pfizer Inc

Find a price of Minocycline Hydrochloride bulk offered by Pfizer Inc

Find a price of Minoxidil bulk offered by Pfizer Inc

Find a price of Mithramycin bulk offered by Pfizer Inc

Find a price of Neomycin Sulfate bulk offered by Pfizer Inc

Find a price of Nicotine bulk offered by Pfizer Inc

Find a price of Nystatin bulk offered by Pfizer Inc

Find a price of Olsalazine bulk offered by Pfizer Inc

Find a price of Oxytetracycline Calcium bulk offered by Pfizer Inc

Find a price of Oxytetracycline Dihydrate bulk offered by Pfizer Inc

Find a price of Oxytetracycline Hydrochloride bulk offered by Pfizer Inc

Find a price of Penicillin G Benzathine bulk offered by Pfizer Inc

Find a price of Penicillin G Procaine bulk offered by Pfizer Inc

Find a price of Penicillin V Potassium bulk offered by Pfizer Inc

Find a price of Pentostatin bulk offered by Pfizer Inc

Find a price of Phenytoin Sodium bulk offered by Pfizer Inc

Find a price of Polyethylene Glycol Monostearate bulk offered by Pfizer Inc

Find a price of Prednisolone bulk offered by Pfizer Inc

Find a price of Prednisolone Sodium Phosphate bulk offered by Pfizer Inc

Find a price of Prednisone bulk offered by Pfizer Inc

Find a price of Prednisone Acetate bulk offered by Pfizer Inc

Find a price of Reserpine bulk offered by Pfizer Inc

Find a price of Rifabutin bulk offered by Pfizer Inc

Find a price of Silicon Dioxide API bulk offered by Pfizer Inc

Find a price of Spectinomycin HCl bulk offered by Pfizer Inc

Find a price of Streptomycin bulk offered by Pfizer Inc

Find a price of Tazobactam Sodium bulk offered by Pfizer Inc

Find a price of Testolactone bulk offered by Pfizer Inc

Find a price of Testosterone Enanthate bulk offered by Pfizer Inc

Find a price of Tetracycline bulk offered by Pfizer Inc

Find a price of Tetracycline Hydrochloride bulk offered by Pfizer Inc

Find a price of Tinidazole bulk offered by Pfizer Inc

Find a price of Tirilazad bulk offered by Pfizer Inc

Find a price of Tolbutamide bulk offered by Pfizer Inc

Find a price of Tranexamic Acid bulk offered by Pfizer Inc

Find a price of Treprostinil Sodium bulk offered by Pfizer Inc

Find a price of Triazolam bulk offered by Pfizer Inc

Find a price of Troleandomycin bulk offered by Pfizer Inc

Find a price of Vancomycin Hydrochloride bulk offered by Pfizer Inc

Find a price of Vidarabine bulk offered by Pfizer Inc

Find a price of Viomycin Sulfate bulk offered by Pfizer Inc

Find a price of Zinc Gluconate API bulk offered by Pfizer Inc

Find a price of (U-31, 583) 1-B-D-ARABINOFURANOSYLCYTOSINE 5'-PALMITATE bulk offered by Pfizer Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN ARNPRIOR, ONTARIO, CANADA. bulk offered by Pfizer Inc

Find a price of MANUFACTURING ,PACKAGING AND CONTROLS PROCEDURES-THIS IS A VET MED DMF bulk offered by Pfizer Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN HILLEROD, DENMARK. bulk offered by Pfizer Inc

Find a price of MANUFACTURING SITE FACILITIES OPERATING PROCEDURES AND PERSONNEL OF THE GS/API PROCESS R&D PLANT IN NERVIANO ITALY bulk offered by Pfizer Inc

Find a price of CAPSULE PLANT OPERATION AT THE DETROIT, MICHIGAN FACILITY bulk offered by Pfizer Inc

Find a price of METHODS, FACILITIES AND CONTROLS bulk offered by Pfizer Inc

Find a price of 17-DESOXY OXIDO bulk offered by Pfizer Inc

Find a price of FACILITY AND OPERATING PROCEDURES IN STOCKHOLM, SWEDEN bulk offered by Pfizer Inc

Find a price of VIRAL AND BACTERIAL VACCINE bulk offered by Pfizer Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MILAN, ITALY. bulk offered by Pfizer Inc

Find a price of CLINICAL INVESTIGATION--CI-383 bulk offered by Pfizer Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES bulk offered by Pfizer Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GWENT, UNITED KINGDOM. bulk offered by Pfizer Inc

Find a price of GEN. INFO APPLICABLE TO THE FINE CHEMICAL OPERATIONS bulk offered by Pfizer Inc

Find a price of CLINICAL INVESTIGATIONS--CI 400 AND 421 bulk offered by Pfizer Inc

Find a price of PERSONNEL, FACILITIES & GENERAL OPERATING PROCEDURES bulk offered by Pfizer Inc

Find a price of ANTIBIOTIC GENERAL INFORMATION bulk offered by Pfizer Inc

Find a price of CLINICAL INVESTIGATION--CI-446 bulk offered by Pfizer Inc

Find a price of MANFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN JOHANNESHOV, SWEDEN. bulk offered by Pfizer Inc

Find a price of QUALITY CONTROL INFORMATION FOR NDA ANTIBIOTIC bulk offered by Pfizer Inc

Find a price of NSC-51173, (U-10955)--5A-ANDROSTAN-3-ONE,2A-FLUORO-17B-HYDROXY bulk offered by Pfizer Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN PARSIPPANY, NEW JERSEY. bulk offered by Pfizer Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES OF LARGE VOLUME PARENTERALS IN GLASS BOTTLES IN UPPSALS, SWEDEN. bulk offered by Pfizer Inc

Find a price of PERSONNEL, FACILS & GEN OPER PROCEDS AT THE LITITZ, PA FACILITY bulk offered by Pfizer Inc

Find a price of U-32, 070E (25-HYDROXYCHOLECALCIFEROL) bulk offered by Pfizer Inc

Find a price of FACILS. & CONTROLS LOCATED IN FJARDO, PUERTO RICO FACILITY bulk offered by Pfizer Inc

Find a price of IODODOXORUBICIN HCL FOR INJECTION bulk offered by Pfizer Inc

Find a price of SOLKETAL(GLYCEROL 1,2 - ISOPROPYLIDENE ETHER) bulk offered by Pfizer Inc

Find a price of BIZELESIN (U-77779) DRUG SUBSTANCE bulk offered by Pfizer Inc

Find a price of FACILITY AND OPERATING PROCEDURES IN STRANGNAS, SWEDEN bulk offered by Pfizer Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN BRISTOL, TENNESSEE. bulk offered by Pfizer Inc

Find a price of POLYMYXIN METHANE SULFONATE FOR TREAT. OF DISEASE IN POULTRY (VET) bulk offered by Pfizer Inc

Find a price of CLINICAL INVESTIGATION--CI-462 bulk offered by Pfizer Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN UPPSALA, SWEDEN. bulk offered by Pfizer Inc

Find a price of CLINICAL INVESTIGATION--CI 344 bulk offered by Pfizer Inc

Find a price of BULK CHEMICALS , METHOD OF PREPARATION bulk offered by Pfizer Inc

Find a price of QUALIFICATIONS OF PARKE, DAVIS & CO. RESEARCH PERSONNEL bulk offered by Pfizer Inc

Find a price of PACKAGING OPERATION bulk offered by Pfizer Inc

Find a price of CLINICAL INVESTIGATION--CI423 bulk offered by Pfizer Inc

Find a price of MFG, PROCESS & PACK OF INDS IN MORRIS PLAINS, NJ FACIL (710 TABOR RD) bulk offered by Pfizer Inc

Find a price of COMBINED ADRENAL HORMONE ANTIBIOTIC THERAPY bulk offered by Pfizer Inc

Find a price of CLINICAL INVESTIGATION 461 bulk offered by Pfizer Inc

Find a price of CI -404 - ACTINOBOLIN SULFATE bulk offered by Pfizer Inc

Find a price of MANUFACTURING SITE, FACILITIES, OPERATING PROCEDURES AND PERSONNEL IN UPPSALA, SWEDEN. bulk offered by Pfizer Inc

Find a price of OLEANSOMYCIN AND COCCIDIOSTATS IN POULTRY FEED bulk offered by Pfizer Inc

Find a price of W 3361, A LIQUID ANTACID FORMULATION ---CHITOSAN ANTACID bulk offered by Pfizer Inc

Find a price of WARNER-LAMBERT, CAPS PLANT OPER, BROCKVILLE, ONTARIO, CAN FACILITY bulk offered by Pfizer Inc

Find a price of 16-METHYLDIOLONE ACETATE AND S.D. VII) 9(11)-ANHYDRO-16a METHYLPREDNIS bulk offered by Pfizer Inc

Find a price of STYRENE - MALEIC ACID COPOLYMER-TOXIC. DATA, CLIN REPTS & PHYSI CHARAC bulk offered by Pfizer Inc

Find a price of IODODOXORUBICIN HCL BULK DRUG SUBSTANCE bulk offered by Pfizer Inc

Find a price of FACILITY, PERSONNEL AND OPERATING PROCEDURES IN STOCKHOLM, SWEDEN bulk offered by Pfizer Inc

Find a price of 1-DESOXYEPHEDRINE bulk offered by Pfizer Inc

Find a price of FACILITY AND OPERATING PROCEDURES AT THE BRUNNA FACILITY IN KUNGSANGEN, SWEDEN bulk offered by Pfizer Inc

Find a price of METHODS, FACILS & CONTRLS bulk offered by Pfizer Inc

Find a price of FACILITIES, PERSONNEL & EQUIPMENT IN SANDWICH, KENT, ENGLAND bulk offered by Pfizer Inc

Find a price of CLINICAL INVESTIGATION-- CI-395 bulk offered by Pfizer Inc

Find a price of VIRAL AND BACTERIAL VACCINES bulk offered by Pfizer Inc

Find a price of CLINICAL INVESTIGATION--CI 384 bulk offered by Pfizer Inc

Find a price of PERSONNEL FACILITIES AND OPERATING PROCEDURE bulk offered by Pfizer Inc

Find a price of MANUFACTURING FACILITIES IN COLUMBUS, OHIO bulk offered by Pfizer Inc

Find a price of FACILITIES & GENERAL OPERATING PROCEDURES (SANDY, UTAH LOCATION) bulk offered by Pfizer Inc

Find a price of PELLETHANE MDI BASED URETHANE ELASTOMER bulk offered by Pfizer Inc

Find a price of CLINICAL INVESTIGATION --CI 442 bulk offered by Pfizer Inc

Find a price of HYDROXY ACID bulk offered by Pfizer Inc

Find a price of ARA-CYTIDINE 5 - BENZOATE (U - 32,072E) bulk offered by Pfizer Inc

Find a price of FACILITIES AND CONTROLS IN WEST SUSSEX, U.K. bulk offered by Pfizer Inc

Find a price of AT THE CHRISTIANSTED, ST. CROIX LOCATION bulk offered by Pfizer Inc

Find a price of Hydrocortisone Acetate bulk offered by Pfizer Inc

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty